Dabrafenib/trametinib

Korman AM, et al. Subclinical granulomas in benign skin lesions heralding the onset of BRAF and MEK inhibitor-associated granulomatous dermatitis in a patient with metastatic melanoma. JAAD Case Reports 4: 722-724, No. 7, Aug 2018. Available from: URL: http://doi.org/10.1016/j.jdcr.2018.05.011 - USACrossRefPubMedPubMedCentralGoogle Scholar